KRAS P.G12C

Clinical trials for KRAS P.G12C explained in plain language.

Never miss a new study

Get alerted when new KRAS P.G12C trials appear

Sign up with your email to follow new studies for KRAS P.G12C, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.

Our safety recommendation!

By submitting, you agree to our Terms of use

Trials to join now! 4 Not yet finished but already full! 1 Completed 1

New hope for elderly lung cancer patients: targeted pill shows promise

Disease control Ongoing

This study tests a daily pill called adagrasib in 68 patients with a specific type of advanced lung cancer (KRAS G12C mutation) who are either 70 or older or have poor physical health. The goal is to see if the drug can shrink tumors or stop them from growing. Patients take the m…

Matched conditions: KRAS P.G12C

Phase: PHASE2 • Sponsor: ETOP IBCSG Partners Foundation • Aim: Disease control

Last updated Jun 27, 2026 14:01 UTC

KRAS P.G12C

Get alerted when new KRAS P.G12C trials appear

New hope for elderly lung cancer patients: targeted pill shows promise